We therefore investigated tumors with six distinct HLA alleles and loss of one HLA haplotype (HLA-A, HLA-B, and HLA-C) in at least one tumor region (n = 20; 9 lung adenocarcinomas and 11 lung squamous cell carcinoma). Here, HLA-C is linked to neoplasm.